# XTRENBO

NDC: 0143-9166
Generic name: Denosumab-qbde
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20260108

FDA application: BLA761439

## Active ingredients

- DENOSUMAB: 120 mg/1.7mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9166"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9166
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a48a3a33-6b0e-4cf4-8786-8f662d6ee77b